3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
220
INDUSTRY
117
NIH
42
NETWORK
6
OTHER_GOV
5
INDIV
1
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Fanconi Anemia, Complementation Group N
1
Fanconi Anemia, Complementation Group D1
1
Interventions
Exercise
6
pembrolizumab
5
enzalutamide
4
Docetaxel
4
Colonoscopy
4
Celecoxib
4
sargramostim
3
apalutamide
3
Prednisone
3
Methods
3
Leuprolide
3
Itraconazole
3
Imiquimod
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Golytely
3
Cryotherapy
3
Abiraterone Acetate
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
abiraterone
2
Yoga
2
Topotecan
2
Testosterone
2
Tablets
2
Simvastatin
2
Radiosurgery
2
Palliative Care
2
Midazolam
2
Gelatin
2
Decision Support Techniques
2
Collagenases
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
FED
×
Interventional
×
olaparib
×
Clear all
NCT04038502
2025-08-20
COBRA
VA Office of Research and Development
Phase 2
Recruiting
100 enrolled